Find a Physician

Profile http://stanfordhospital.org/profiles/Lawrence_Steinman/
Email this profile
Portrait View Larger

Lawrence Steinman

Academic Appointments

  • George A. Zimmermann Professor and Professor of Pediatrics

Key Documents

Contact Information

  • Clinical Offices
    Child Neurology 730 Welch Rd 2nd Fl Palo Alto, CA 94304
    Tel Work (650) 723-0993 Fax (650) 721-6350
  • Academic Offices
    Personal Information
    Email Tel (650) 725-6401
    Not for medical emergencies or patient use

Professional Overview

Clinical Focus

  • Neurology
  • Neurology, Pediatric
  • Multiple Sclerosis, Myasthenia Gravis, Immune Disorders

Academic Appointments

Administrative Appointments

  • Chairman, Interdepartmental Program in Immunology, Interdepartmental Program in Immunology, Stanford University (2002 - 2011)

Honors and Awards

  • Charcot Award for Lifetime Achievement in MS Research, Internation Federation of MS Societies (2011)
  • Member, Institute of Medicine, National Academy of Sciences (October, 2009-)
  • John M. Dystel Prize, American Academy of Neurology and National MS Society (2004)
  • Friedrich Sasse Prize, Free Univ.of Berlin (1994)
  • Sen. Jacob Javits Award, US Congress (1988-2002)

Professional Education

Residency: Stanford University School of Medicine CA (1980)
Residency: Stanford University School of Medicine CA (1974)
Fellowship: National Institutes of Health MD (1977)
Board Certification: Neurology, American Board of Psychiatry and Neurology (1984)
Fellowship: Weizmann Institute Of Science, Israel (1977)
Internship: Stanford University School of Medicine CA (1974)
View All 8

Courses

2013-14

Prior Year Coursescourses of Lawrence Steinman

Graduate and Fellowship Program Affiliations

Scientific Focus

Current Research and Scholarly Interests

Our laboratory is dedicated to understanding the pathogenesis of autoimmune diseases, particularly multiple sclerosis. We have developed several new therapies for autoimmunity, including some in Phase 2 clinical trials, as well as one approved drug, natalizumab. We have developed microarray technology for detecting autoantibodies to myelin proteins and lipids. We employ a diverse range of molecular and celluar approaches to trying to understand multiple sclerosis.

Clinical Trials

Publications

Publication tag cloud

Publication Topics

View All 358

Stanford Medicine Resources:

Footer Links: